Evidence map›Paper›PMID 30131435›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2018

Prevention of Lipid Peroxidation-derived Cyclic DNA Adduct and Mutation in High-Fat Diet-induced Hepatocarcinogenesis by Theaphenon E.

Heidi Coia, Ning Ma, Yanqi Hou, Marcin D Dyba, Ying Fu, M Idalia Cruz, Carlos Benitez, Garrett T Graham, Justine N McCutcheon, Yun-Ling Zheng and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Ginsenoside RgNutrients · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Heidi CoiaDepartment of Biochemistry & Molecular Biology, Georgetown University Medical Center, Washington DC.
Ning Ma *Department of Biochemistry & Molecular Biology, Georgetown University Medical Center, Washington DC.
Yanqi Hou *Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC.ORCID 0000-0003-2170-339X
Marcin D DybaDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC.
Ying FuDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC.
M Idalia CruzDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC.
Carlos BenitezDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC.
Garrett T GrahamDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC.
Justine N McCutcheonDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC.
Yun-Ling ZhengDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC.
Bing SunDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC.
Bhaskar V KallakuryDepartment of Pathology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington.
Junfeng MaDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC.
Hong-Bin FangDepartment of Biostatistics, Bioinformatics and Biomathematics, Georgetown University, Washington DC.ORCID 0000-0002-6173-9082
Deborah L BerryDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC.
Vinona MuralidaranDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC.ORCID 0000-0002-0544-495X
Fung-Lung ChungDepartment of Biochemistry & Molecular Biology, Georgetown University Medical Center, Washington DC. flc6@georgetown.edu.
Georgetown University · US

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI Louis M Weiner · 1990 to 2026
$71.5M
TRAINING GRANT IN TUMOR BIOLOGYT32CA009686 · NCI · GEORGETOWN UNIVERSITY · PI ANNA Tate RIEGEL, DAVID J ROBBINS · 1996 to 2026
$10.8M
Lipid-Peroxidation Induced Cyclic Adducts in HepatocarcinogenesisR01CA134892 · NCI · GEORGETOWN UNIVERSITY · PI CHUNG, FUNG-LUNG · 2009 to 2013
$2.1M
Mechanisms of obesity-induced hepatocarcinogenesisR01CA190678 · NCI · GEORGETOWN UNIVERSITY · PI CHUNG, FUNG-LUNG, TANG, ERIC MOON-SHONG M. · 2015 to 2019
$1.8M
NCI NIH HHS P30 CA051008NCI NIH HHS R01 CA134892NCI NIH HHS R01 CA190678NCI NIH HHS T32 CA009686
6 · The paper itself

Abstract

Obesity is associated with cancer risk and its link with liver cancer is particularly strong. Obesity causes non-alcoholic fatty liver disease (NAFLD) that could progress to hepatocellular carcinoma (HCC). Chronic inflammation likely plays a key role. We carried out a bioassay in the high-fat diet (HFD)-fed C57BL/6J mice to provide insight into the mechanisms of obesity-related HCC by studying γ-OHPdG, a mutagenic DNA adduct derived from lipid peroxidation. In an 80-week bioassay, mice received a low-fat diet (LFD), high-fat diet (HFD), and HFD with 2% Theaphenon E (TE) (HFD+TE). HFD mice developed a 42% incidence of HCC and LFD mice a 16%. Remarkably, TE, a standardized green tea extract formulation, completely blocked HCC in HFD mice with a 0% incidence. γ-OHPdG measured in the hepatic DNA of mice fed HFD and HFD+TE showed its levels increased during the early stages of NAFLD in HFD mice and the increases were significantly suppressed by TE, correlating with the tumor data. Whole-exome sequencing showed an increased mutation load in the liver tumors of HFD mice with G>A and G>T as the predominant mutations, consistent with the report that γ-OHPdG induces G>A and G>T. Furthermore, the mutation loads were significantly reduced in HFD+TE mice, particularly G>T, the most common mutation in human HCC. These results demonstrate in a relevant model of obesity-induced HCC that γ-OHPdG formation during fatty liver disease may be an initiating event for accumulated mutations that leads to HCC and this process can be effectively inhibited by TE.

Indexed as

AnimalsCarcinogenesisCarcinoma, HepatocellularDiet, High-FatDNA AdductsDrug Screening Assays, AntitumorExome SequencingIncidenceLipid PeroxidationLiverLiver Neoplasms, ExperimentalMaleMiceMice, Inbred C57BLMutation RateObesityDNA AdductsPlant ExtractsPolyphenolsTea

Identifiers

PMID30131435
PMCPMC6171362
OpenAlexW2888070124

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.